Hypertension Institute, Nashville Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2017
NCT03895749
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Hypertension Institute, Nashville

Active Ingredients

Drugs in Other Trials (4)

cobalamin (1 trial)

crataegus (1 trial)

n5-carbamoylornithine (1 trial)

vitamin c (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 4